Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible?
Chronic heart failure (CHF) is a complex clinical syndrome characterized by poor prognosis. According to the Russian epidemiological study EPOHA-CHF, more than half of patients with CHF have preserved left ventricular ejection fraction (LV EF). However, no class of drugs has proven effectiveness in...
Saved in:
| Main Authors: | V. D. Zakiev, N. M. Vorobyeva, I. P. Malaya, A. D. Gvozdeva, O. N. Tkacheva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2023-12-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2987 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beta-Blockers After PCI for Stable Coronary Artery Disease and Preserved Left Ventricular Ejection Fraction
by: Safi U. Khan, MD, MS, et al.
Published: (2025-02-01) -
Continuation vs Withdrawal of Beta-Blockers and Outcomes After Myocardial Infarction With Preserved Left Ventricular Function
by: Michael H. Chiu, MD, MSc, et al.
Published: (2025-06-01) -
The US Deprescribing Research Network: a network to catalyze deprescribing science
by: Raha Shahroodi, et al.
Published: (2025-07-01) -
Beta blockers and their combinations in the management of hypertension
by: J.A. Ker
Published: (2012-10-01) -
Beta-blockers in modern glaucoma therapy. Review
by: O. A. Kiseleva, et al.
Published: (2014-07-01)